Wojciech Jurczak - Dissemin

Language
Login

All papers authored by Wojciech Jurczak

This paper is made freely available by the publisher.

2022 Constantine S. Tam

ORCID

, Meletios Dimopoulos, Ramon Garcia-Sanz, Judith Trotman

ORCID

, Stephen Opat, Andrew W. Roberts

ORCID

, Roger Owen, Yuqin Song, Wei Xu, Jun Zhu, Jianyong Li, Lugui Qiu, Shirley D’Sa, Wojciech Jurczak

ORCID

, Gavin Cull and 14 other authors

Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies

Download from doi.org

Distributing this paper is prohibited by the publisher

2020 Constantine S. Tam

ORCID

, Stephen Opat, Shirley D'Sa, Wojciech Jurczak

ORCID

, Hui-Peng Lee, Gavin Cull, Roger G. Owen, Paula Marlton, Björn E. Wahlin, Ramón Garcia Sanz

ORCID

, Helen McCarthy, Stephen Mulligan, Alessandra Tedeschi, Jorge J. Castillo, Jaroslaw Czyz

ORCID

and 18 other authors

A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study

Upload

This paper is made freely available by the publisher.

2018 Monika Długosz-Danecka, Wojciech Jurczak

ORCID

, Ewa Łątka-Cabała, Marta Morawska, Krzysztof Gawroński, Anna Wiśniewska, Marek Dudziński, Ewa Wąsik-Szczepanek, Ewa Chmielowska, Anna Łabędź, Kamil Wdowiak, Iwona Hus

Efficacy and safety of the obinutuzumab-chlorambucil combination in the frontline treatment of elderly CLL patients with comorbidities – Polish Adult Leukemia Group (PALG) real-life analysis

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Tomasz Wróbel, Przemysław Biecek

ORCID

, Justyna Rybka, Anna Szulgo, Natalia Sorbotten, Agnieszka Giza, Agata Tyczyńska, Elżbieta Nowara, Agnieszka Badora-Rybicka, Krzysztof Adamowicz, Waldemar Kulikowski, Renata Kroll-Balcerzak, Andrzej Balcerzak, Wojciech Spychałowicz, Ewa Kalinka-Warzocha and 13 other authors

Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group

Upload

This paper is made freely available by the publisher.

Stephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig, Peter Hillmen, John F. Seymour, Steven Coutre, Wojciech Jurczak

ORCID

, Stephen P. Mulligan, Anna Schuh, Sarit Assouline, Clemens-Martin Wendtner, Andrew W. Roberts, Matthew S. Davids, Johannes Bloehdorn

ORCID

, Talha Munir and 11 other authors

Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Ajay K. Gopal, Stephen J. Schuster, Nathan H. Fowler, Judith Trotman, Georg Hess, Jing-Zhou Hou, Abdulraheem Yacoub, Michael Lill, Peter Martin, Umberto Vitolo, Andrew Spencer, John A. Radford, Wojciech Jurczak

ORCID

, James Morton, Dolores Caballero and 9 other authors

Ibrutinib as treatment for patients with relapsed/refractory follicular lymphoma: results from the open-label, multicenter, phase II DAWN study.

Upload

This paper was not found in any repository, but could be made available legally by the author.

Farrukh T. Awan, Wojciech Jurczak

ORCID

Use of acalabrutinib in patients with mantle cell lymphoma

Upload

This paper is made freely available by the publisher.

W. Jurczak

ORCID

, P. L. Zinzani, G. Gaidano, A. Goy, M. Provencio

ORCID

, Z. Nagy, T. Robak, K. Maddocks, C. Buske, S. Ambarkhane, M. Winderlich, M. Dirnberger-Hertweck, R. Korolkiewicz, K. A. Blum

Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma

Download from doi.org

This paper is made freely available by the publisher.

S. Rule

ORCID

, W. Jurczak

ORCID

, M. Jerkeman, C. Rusconi, M. Trneny, F. Offner, D. Caballero, C. Joao

ORCID

, M. Witzens-Harig, G. Hess, I. Bence-Bruckler, S.-G. Cho

ORCID

, C. Thieblemont, W. Zhou, T. Henninger and 3 other authors

Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

Download from doi.org

This paper is available in a repository.

L. Arcaini, T. Lamy, J. Walewski

ORCID

, D. Belada, J. Mayer, John A. Radford, W. Jurczak

ORCID

, F. Morschhauser, J. Alexeeva, S. Rule, J. Cabeçadas, E. Campo, S. A. Pileri, T. Biyukov, M. Patturajan and 2 other authors

Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma.

Download from onlinelibrary.wiley.com

This paper is available in a repository.

2017 Joseph M. Connors, Connors Jm, Wojciech Jurczak

ORCID

, David J. Straus, Stephen M. Ansell, Won S. Kim, Straus Dj, Andrea Gallamini, Ansell Sm, Anas Younes, Sergey Alekseev, Árpád Illés, A. Illés, Marco Picardi, Ewa Lech-Maranda and 20 other authors

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma

Download from europepmc.org

This paper was not found in any repository, but could be made available legally by the author.

Michael Wang, Simon Rule, Pier Luigi Zinzani, Andre Goy, Olivier Casasnovas

ORCID

, Stephen D. Smith, Gandhi Damaj, Jeanette Doorduijn, Thierry Lamy, Franck Morschhauser, Carlos Panizo

ORCID

, Bijal Shah, Andrew Davies, Richard Eek, Jehan Dupuis and 14 other authors

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Wojciech Jurczak

ORCID

, Arnold G. Vulto, Jutta Amersdorffer, Won S. Kim, Bertrand Coiffier

Research on Biosimilars: pivotal trials and principles

Upload

This paper is made freely available by the publisher.

Wojciech Jurczak

ORCID

, Sundra Ramanathan, Pratyush Giri, Alessandra Romano, Heidi Mocikova, Jill Clancy, Mariajose Lechuga, Michelle Casey, Joseph Boni, Agnieszka Giza, Georg Hess

Comparison of two doses of intravenous temsirolimus in patients with relapsed/refractory mantle cell lymphoma

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Wojciech Jurczak

ORCID

, Ilídia Moreira, Govind Babu Kanakasetty, Eduardo Munhoz, Maria Asunción Echeveste, Pratyush Giri, Nelson Castro, Juliana Pereira

ORCID

, Luiza Akria, Sergey Alexeev, Eugeniy Osmanov, Peijuan Zhu, Siyka Alexandrova, Angela Zubel, Olof Harlin and 1 other authors

Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study

Upload

This paper was not found in any repository, but could be made available legally by the author.

Won Seog Kim, Christian Buske, Michinori Ogura, Wojciech Jurczak

ORCID

, Juan-Manuel Sancho, Edvard Zhavrid, Jin Seok Kim, José-Ángel Hernández-Rivas, Aliaksandr Prokharau, Mariana Vasilica, Rajinish Nagarkar, Dzhelil Osmanov, Larry W. Kwak, Sang Joon Lee, Sung Young Lee and 2 other authors

Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Georg Hess, Simon Rule, Wojciech Jurczak

ORCID

, Mats Jerkeman, Rodrigo Santucci Silva, Chiara Rusconi, Dolores Caballero, Cristina Joao

ORCID

, Mathias Witzens-Harig, Isabelle Bence-Bruckler, Seok-Goo Cho, Wenjiong Zhou, Jenna D. Goldberg, Cristina Trambitas, Christopher Enny and 5 other authors

Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus

Upload

This paper was not found in any repository, but could be made available legally by the author.

Sebastian Szmit, Wojciech Jurczak

ORCID

, Jan Maciej Zaucha, Monika Długosz-Danecka, Barbara Sosnowska-Pasiarska, Ewa Chmielowska, Monika Joks, Joanna Drozd-Sokołowska, Wanda Knopińska-Posłuszny, Wojciech Spychałowicz, Beata Kumiega, Grzegorz Charliński, Marta Morawska, Grzegorz Słomian

Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders

Upload

This paper was not found in any repository, but could be made available legally by the author.

Andrew D. Zelenetz, Jacqueline C. Barrientos, Jennifer R. Brown, Bertrand Coiffier, Julio Delgado, Miklós Egyed, Paolo Ghia, Árpád Illes, Wojciech Jurczak

ORCID

, Paula Marlton, Marco Montillo, Franck Morschhauser, Alexander S. Pristupa, Tadeusz Robak, Jeff P. Sharman and 8 other authors

Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Krzysztof Giannopoulos, Tomasz Wróbel, Wojciech Jurczak

ORCID

, Sebastian Giebel, Iwona Hus, Wiesław Wiktor Jędrzejczak, Tadeusz Robak

Rytuksymab – pierwsze biopodobne przeciwciała monoklonalne w hematoonkologii

Upload

Missing publications? Search for publications with a matching author name.